ICL Group
ICL
4.08
-0.06
-1.45%
ICL Group
US · ICL
#1851 by market cap
Listed 1970
4.08
-0.06
-1.45%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Company notice
ICL Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]SEC · 2026/11/11
-
Rating change
KingMed Diagnostics (603882): The ICL industry is gradually stabilizing, and the company's profitability has improved significantly.Citic Securities · 2026/9/30
-
ICL Group Q3 2026 Earnings Conference Call TranscriptCSOP · 2026/11/12
-
Rating change
Barclays Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6Market Newswire · 2026/7/27
-
Rating change
Morgan Stanley Initiates ICL Group(ICL.US) With Hold Rating, Announces Target Price $5.45Market Newswire · 2026/10/16
-
BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6Market Newswire · 2026/11/12
-
Rating change
ICL Group Is Maintained at Equal-Weight by BarclaysDow Jones · 2026/5/18
-
Barclays Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6Market Newswire · 2026/11/11
-
Rating change
Barclays Maintains Equal-Weight on ICL Group, Raises Price Target to $7Benzinga · 2026/5/18
-
Company notice
ICL Group | 6-K: Report of foreign private issuer (related to financial reporting)SEC · 2026/11/11
-
Aier Eye Hospital (300015.SZ): In the third quarter of 2026, the proportion of advanced surgical procedures such as ICL V5, SMILE Pro, and Quan Guang Su continued to rise, driving a significant sequential increase in revenue.Gelonghui Finance · 2026/11/12
-
Company notice
ICL Group | 6-K: Report of foreign private issuer (related to financial reporting)SEC · 2026/11/11
-
Rating change
ICL Group Price Target Raised to $7.00/Share From $6.00 by BarclaysDow Jones · 2026/5/18
-
Company notice
ICL Group | SCHEDULE 13G: OthersSEC · 2026/11/3
-
ICL Group To Go Ex-Dividend On December 2nd, 2026 With 0.0488 USD Dividend Per ShareMarket Newswire · 2026/11/12
-
Company notice
ICL Group | 6-K: Report of foreign private issuer (related to financial reporting)SEC · 2026/11/11
-
Rating change
BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $6.5Market Newswire · 2026/5/20
-
Rating change
Morgan Stanley Initiates ICL Group(ICL.US) With Hold Rating, Announces Target Price $5.75Market Newswire · 2026/8/10
-
Rating change
BMO Capital Maintains ICL Group(ICL.US) With Hold Rating, Cuts Target Price to $6Market Newswire · 2026/8/6
-
Rating change
Morgan Stanley Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $5.6Market Newswire · 2026/7/22
-
Barclays Maintains ICL Group(ICL.US) With Hold Rating, Maintains Target Price $6Market Newswire · 2026/10/16
-
Company notice
ICL Group | 4: Statement of changes in beneficial ownership of securitiesSEC · 2026/8/6
-
Company notice
ICL Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]SEC · 2026/9/18
-
Rating change
Barclays Maintains ICL Group(ICL.US) With Hold Rating, Raises Target Price to $7Market Newswire · 2026/5/18
-
Company notice
ICL Group | SD: Specialized disclosure reportSEC · 2026/9/25
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
ICL Group discussion 0 comments